Informatie:
Fout:
ID
12475
Beschrijving
The study is designed to compare the efficacy and safety profile of cangrelor to standard of care in patients require percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01156571
Link
https://clinicaltrials.gov/ct2/show/NCT01156571
Trefwoorden
Versies (1)
- 21-11-15 21-11-15 -
Geüploaded op
21 november 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility CHAMPION PHOENIX Acute Coronary Syndrome NCT01156571
Eligibility Criteria
- StudyEvent: ODM
Similar models
Eligibility Criteria
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Gender
Item
Male or non-pregnant female
boolean
C0079399 (UMLS CUI-1)
Pregnancy
Item
non-pregnant female
boolean
C0549206 (UMLS CUI-1)
Age
Item
at least 18 years of age
boolean
C0001779 (UMLS CUI-1)
PCI
Item
Patients undergoing percutaneous coronary intervention (PCI)
boolean
C1532338 (UMLS CUI-1)
Angina pectoris
Item
Stable angina (SA) patients
boolean
C0002962 (UMLS CUI-1)
Coronary angiography
Item
with diagnostic coronary angiography
boolean
C0085532 (UMLS CUI-1)
NSTEMI
Item
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
boolean
C3537184 (UMLS CUI-1)
Acute coronary syndrome
Item
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
boolean
C0948089 (UMLS CUI-1)
STEMI
Item
ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)
boolean
C1536220 (UMLS CUI-1)
Informed consent
Item
Provide written informed consent
boolean
C0021430 (UMLS CUI-1)
Thienopyridines
Item
Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization
boolean
C2936588 (UMLS CUI-1)
Eptifibatide
Item
Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
boolean
C0253563 (UMLS CUI-1)
Tirofiban
Item
Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
boolean
C0247025 (UMLS CUI-1)
Abciximab
Item
Abciximab usage within 7 days preceding randomization
boolean
C0288672 (UMLS CUI-1)
Thrombolytic Therapy
Item
Receipt of fibrinolytic therapy in the 12 hours preceding randomization
boolean
C0040044 (UMLS CUI-1)
Bleeding risk
Item
Increased bleeding risk
boolean
C3251812 (UMLS CUI-1)
Stroke
Item
ischemic stroke within the last year or any previous hemorrhagic stroke
boolean
C0038454 (UMLS CUI-1)
Tumor
Item
tumor
boolean
C0006826 (UMLS CUI-1)
Cerebral arteriovenous malformation
Item
cerebral arteriovenous malformation
boolean
C0003857 (UMLS CUI-1)
intracranial aneurysm
Item
intracranial aneurysm
boolean
C0007766 (UMLS CUI-1)
Trauma
Item
recent (<1 month) trauma
boolean
C3263723 (UMLS CUI-1)
Major surgery
Item
major surgery (including bypass surgery)
boolean
C0679637 (UMLS CUI-1)
Warfarin
Item
currently receiving warfarin
boolean
C0043031 (UMLS CUI-1)
Hemorrhage
Item
active bleeding
boolean
C0019080 (UMLS CUI-1)